Development of a Bamlanivimab Infusion Process in the Emergency Department for Outpatient COVID-19 Patients

The coronavirus disease 2019 (COVID-19) pandemic has prompted the creation of new therapies to help fight against the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Bamlanivimab is a SARS-CoV-2 monoclonal antibody that is administered as an intravenous infusion to ambulatory pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Danny H., Wong, Sandy, Nguyen, Christina T., Lee, Stephen C., Won, Kimberly J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775801/
https://www.ncbi.nlm.nih.gov/pubmed/35052205
http://dx.doi.org/10.3390/healthcare10010042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775801/
https://www.ncbi.nlm.nih.gov/pubmed/35052205
http://dx.doi.org/10.3390/healthcare10010042

Ejemplares similares